These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18712029)

  • 1. A new standardized method of evaluating cutaneous irritation from topical medications.
    Uliasz A; Lebwohl M
    Cutis; 2008 Jul; 82(1):75-7. PubMed ID: 18712029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of sensory irritation caused by topical medications using a novel technique.
    Uliasz A; Lebwohl M
    Int J Dermatol; 2010 Mar; 49(3):269-71. PubMed ID: 20465662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in Cutaneous Irritation of Five Commonly Used Topical Products.
    Draelos ZD
    J Drugs Dermatol; 2016 Jul; 15(7):870-3. PubMed ID: 27391638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative skin irritation test of sanitary pads in sensitive skin and normal skin population.
    Farage MA; Maibach H
    Cutan Ocul Toxicol; 2007; 26(1):37-43. PubMed ID: 17464747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of fluticasone propionate in the topical treatment of skin diseases.
    Roeder A; Schaller M; Schäfer-Korting M; Korting HC
    Skin Pharmacol Physiol; 2005; 18(1):3-11. PubMed ID: 15608497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial.
    Stainer R; Matthews S; Arshad SH; McDonald S; Robinson J; Schapira C; Foote KD; Baird-Snell M; Gregory T; Pollock I; Stevens MT; Edwards AM
    Br J Dermatol; 2005 Feb; 152(2):334-41. PubMed ID: 15727648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of lotion formulations on irritation using the modified forearm-controlled application test method.
    Farage MA; Ebrahimpour A; Steimle B; Englehart J; Smith D
    Skin Res Technol; 2007 Aug; 13(3):268-79. PubMed ID: 17610648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a sensitive test method to evaluate mechanical irritation potential on mucosal skin.
    Farage MA; Meyer S; Walter D
    Skin Res Technol; 2004 May; 10(2):85-95. PubMed ID: 15059175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial.
    Doss N; Reitamo S; Dubertret L; Fekete GL; Kamoun MR; Lahfa M; Ortonne JP
    Br J Dermatol; 2009 Aug; 161(2):427-34. PubMed ID: 19416227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two randomized, double-blind, placebo-controlled studies of fluticasone propionate lotion 0.05% for the treatment of atopic dermatitis in subjects from 3 months of age.
    Eichenfield LF; Miller BH;
    J Am Acad Dermatol; 2006 Apr; 54(4):715-7. PubMed ID: 16546598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of fluticasone propionate ointment, 0.005%, in the treatment of eczema.
    Lebwohl M
    Cutis; 1996 Feb; 57(2 Suppl):62-8. PubMed ID: 8646873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Behind-the-Knee test: an efficient model for evaluating mechanical and chemical irritation.
    Farage MA
    Skin Res Technol; 2006 May; 12(2):73-82. PubMed ID: 16626379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of tacrolimus 0.03% ointment as second-line treatment for children with moderate-to-severe atopic dermatitis: evidence from a randomized, double-blind non-inferiority trial vs. fluticasone 0.005% ointment.
    Doss N; Kamoun MR; Dubertret L; Cambazard F; Remitz A; Lahfa M; de Prost Y
    Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 1):321-9. PubMed ID: 19563466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical fluticasone propionate lotion does not cause HPA axis suppression.
    Hebert AA; Friedlander SF; Allen DB
    J Pediatr; 2006 Sep; 149(3):378-82. PubMed ID: 16939752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of modifications of the traditional patch test in assessing the chemical irritation potential of feminine hygiene products.
    Farage MA; Meyer S; Walter D
    Skin Res Technol; 2004 May; 10(2):73-84. PubMed ID: 15059174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cleansing lotion containing tamarind fruit pulp extract. II. Study of cumulative irritation effects in human.
    Maenthaisong R; Viyoch J; Chaiyakunapruk N; Warnnissorn P
    J Cosmet Dermatol; 2007 Sep; 6(3):178-82. PubMed ID: 17760696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cumulative irritation potential of metronidazole gel compared to azelaic acid gel after repeated applications to healthy skin.
    Ziel K; Yelverton CB; Balkrishnan R; Feldman SR
    J Drugs Dermatol; 2005; 4(6):727-31. PubMed ID: 16302558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical fluticasone propionate: intervention and maintenance treatment options of atopic dermatitis based on a high therapeutic index.
    Korting HC; Schöllmann C
    J Eur Acad Dermatol Venereol; 2012 Feb; 26(2):133-40. PubMed ID: 21977914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited application of fluticasone propionate ointment, 0.005% in patients with psoriasis of the face and intertriginous areas.
    Lebwohl MG; Tan MH; Meador SL; Singer G
    J Am Acad Dermatol; 2001 Jan; 44(1):77-82. PubMed ID: 11148481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of fluticasone propionate 0.005% ointment in the treatment of psoriasis.
    Olsen EA
    Cutis; 1996 Feb; 57(2 Suppl):57-61. PubMed ID: 8646872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.